Inhibition of long non-coding RNA NEAT1 impairs myeloid differentiation in acute promyelocytic leukemia cells

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Zeng, Chengwu ^a,b   Xu, Yan ^a,b   Xu, Ling ^a,b   Yu, Xibao ^a,b   Cheng, Jingjing ^a,b   Yang, Lijian ^a   Chen, Shaohua ^a   Li, Yangqiu ^a,b  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; LONG UNTRANSLATED RNA; NUCLEAR ENRICHED ABUNDANT TRANSCRIPT 1; RETINOIC ACID RECEPTOR ALPHA; RIBONUCLEOPROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; NEAT1 LONG NON-CODING RNA, HUMAN; ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA-RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; RETINOIC ACID;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL NUCLEUS INCLUSION BODY; CELL SURFACE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE INTERACTION; GENE LOCATION; GENE SILENCING; HUMAN; HUMAN CELL; LEUKEMOGENESIS; MALE; MYELOID LEUKEMIA CELL LINE; NEAT1 GENE; PARASPECKLES; PROMYELOCYTIC LEUKEMIA; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RARALPHA GENE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA GENE; UPREGULATION; WESTERN BLOTTING; DRUG EFFECTS; GENETICS; METABOLISM; MIDDLE AGED; NEUTROPHIL; PATHOLOGY; TUMOR CELL LINE; YOUNG ADULT;

ADOLESCENT; ADULT; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; NEUTROPHILS; ONCOGENE PROTEINS, FUSION; RNA, LONG NONCODING; TRETINOIN; YOUNG ADULT;

EID: 84907251049     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-693     Document Type: Article

References (30)

1. de The H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 1991, 66(4):675-684. 10.1016/0092-8674(91)90113-D, 1652369.
2. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu LJ, Wang ZY. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988, 72(2):567-572.
3. Breitman TR, Collins SJ, Keene BR. Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid. Blood 1981, 57(6):1000-1004.
4. Nasr R, Guillemin MC, Ferhi O, Soilihi H, Peres L, Berthier C, Rousselot P, Robledo-Sarmiento M, Lallemand-Breitenbach V, Gourmel B, Vitoux D, Pandolfi PP, Rochette-Egly C, Zhu J, and de The H Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation. Nat Med 2008, 14(12):1333-1342. 10.1038/nm.1891, 19029980, and de The H.
5. Zhu J, Gianni M, Kopf E, Honore N, Chelbi-Alix M, Koken M, Quignon F, Rochette-Egly C, de The H. Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins. Proc Natl Acad Sci U S A 1999, 96(26):14807-14812. 10.1073/pnas.96.26.14807, 24729, 10611294.
6. Isakson P, Bjoras M, Boe SO, Simonsen A. Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein. Blood 2010, 116(13):2324-2331. 10.1182/blood-2010-01-261040, 20574048.
7. Wang K, Wang P, Shi J, Zhu X, He M, Jia X, Yang X, Qiu F, Jin W, Qian M, Fang H, Mi J, Yang X, Xiao H, Minden M, Du Y, Chen Z, Zhang J. PML/RARalpha targets promoter regions containing PU.1 consensus and RARE half sites in acute promyelocytic leukemia. Cancer Cell 2010, 17(2):186-197. 10.1016/j.ccr.2009.12.045, 20159610.
8. Ablain J, de The H. Revisiting the differentiation paradigm in acute promyelocytic leukemia. Blood 2011, 117(22):5795-5802. 10.1182/blood-2011-02-329367, 21444912.
9. Payton JE, Grieselhuber NR, Chang LW, Murakami M, Geiss GK, Link DC, Nagarajan R, Watson MA, Ley TJ. High throughput digital quantification of mRNA abundance in primary human acute myeloid leukemia samples. J Clin Invest 2009, 119(6):1714-1726. 10.1172/JCI38248, 2689138, 19451695.
10. Viale A, De Franco F, Orleth A, Cambiaghi V, Giuliani V, Bossi D, Ronchini C, Ronzoni S, Muradore I, Monestiroli S, Gobbi A, Alcalay M, Minucci S, Pelicci PG. Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells. Nature 2009, 457(7225):51-56. 10.1038/nature07618, 19122635.
11. Sun YM, Lin KY, Chen YQ. Diverse functions of miR-125 family in different cell contexts. J Hematol Oncol 2013, 6:6. 10.1186/1756-8722-6-6, 3566921, 23321005.
12. Zeng CW, Zhang XJ, Lin KY, Ye H, Feng SY, Zhang H, Chen YQ. Camptothecin induces apoptosis in cancer cells via microRNA-125b-mediated mitochondrial pathways. Mol Pharmacol 2012, 81(4):578-586. 10.1124/mol.111.076794, 22252650.
13. Zhang H, Chen Z, Wang X, Huang Z, He Z, Chen Y. Long non-coding RNA: a new player in cancer. J Hematol Onco 2013, 6:37.
14. Zhuang Y, Wang X, Nguyen HT, Zhuo Y, Cui X, Fewell C, Flemington EK, Shan B. Induction of long intergenic non-coding RNA HOTAIR in lung cancer cells by type I collagen. J Hematol Oncol 2013, 6:35. 10.1186/1756-8722-6-35, 3655931, 23668363.
15. Sunwoo H, Dinger ME, Wilusz JE, Amaral PP, Mattick JS, Spector DL. MEN epsilon/beta nuclear-retained non-coding RNAs are up-regulated upon muscle differentiation and are essential components of paraspeckles. Genome Res 2009, 19(3):347-359. 2661813, 19106332.
16. Naganuma T, Hirose T. Paraspeckle formation during the biogenesis of long non-coding RNAs. RNA Biol 2013, 10(3):456-461. 10.4161/rna.23547, 3672290, 23324609.
17. Chen LL, Carmichael GG. Altered nuclear retention of mRNAs containing inverted repeats in human embryonic stem cells: functional role of a nuclear noncoding RNA. Mol Cell 2009, 35(4):467-478. 10.1016/j.molcel.2009.06.027, 2749223, 19716791.
18. Grignani F, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M, Mencarelli A, Grignani F, Peschle C, Nicoletti I, Pelicci PG. The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 1993, 74(3):423-431. 10.1016/0092-8674(93)80044-F, 8394219.
19. Miyake M, Hayashi S, Iwasaki S, Chao G, Takahashi H, Watanabe K, Ohwada S, Aso H, Yamaguchi T. Possible role of TIEG1 as a feedback regulator of myostatin and TGF-beta in myoblasts. Biochem Biophys Res Commun 2010, 393(4):762-766. 10.1016/j.bbrc.2010.02.077, 20171187.
20. Ward SV, Sternsdorf T, Woods NB. Targeting expression of the leukemogenic PML-RARalpha fusion protein by lentiviral vector-mediated small interfering RNA results in leukemic cell differentiation and apoptosis. Hum Gene Ther 2010, 22(12):1593-1598.
21. Imamura K, Imamachi N, Akizuki G, Kumakura M, Kawaguchi A, Nagata K, Kato A, Kawaguchi Y, Sato H, Yoneda M, Kai C, Yada T, Suzuki Y, Yamada T, Ozawa T, Kaneki K, Inoue T, Kobayashi M, Kodama T, Wada Y, Sekimizu K, Akimitsu N. Long noncoding RNA NEAT1-dependent SFPQ relocation from promoter region to paraspeckle mediates IL8 expression upon immune stimuli. Mol Cell 2014, 53(3):393-406. 10.1016/j.molcel.2014.01.009, 24507715.
22. Zhang Q, Chen CY, Yedavalli VS, Jeang KT. NEAT1 long noncoding RNA and paraspeckle bodies modulate HIV-1 posttranscriptional expression. MBio 2013, 4(1):e00596-00512. 3560530, 23362321.
23. Sasaki YT, Ideue T, Sano M, Mituyama T, Hirose T. MENepsilon/beta noncoding RNAs are essential for structural integrity of nuclear paraspeckles. Proc Natl Acad Sci U S A 2009, 106(8):2525-2530. 10.1073/pnas.0807899106, 2650297, 19188602.
24. Duprez E, Wagner K, Koch H, Tenen DG. C/EBPbeta: a major PML-RARA-responsive gene in retinoic acid-induced differentiation of APL cells. EMBO J 2003, 22(21):5806-5816. 10.1093/emboj/cdg556, 275413, 14592978.
25. Schlafli AM, Torbett BE, Fey MF, Tschan MP. BIRC6 (APOLLON) is down-regulated in acute myeloid leukemia and its knockdown attenuates neutrophil differentiation. Exp Hematol Oncol 2012, 1(1):25. 10.1186/2162-3619-1-25, 3514096, 23211188.
26. Rogers CS, Yedjou CG, Sutton DJ, Tchounwou PB. Vitamin D3 potentiates the antitumorigenic effects of arsenic trioxide in human leukemia (HL-60) cells. Exp Hematol Oncol 2014, 3(1):9. 10.1186/2162-3619-3-9, 3973008, 24661615.
27. Chen GQ, Zhu J, Shi XG, Ni JH, Zhong HJ, Si GY, Jin XL, Tang W, Li XS, Xong SM, Shen ZX, Sun GL, Ma J, Zhang P, Zhang TD, Gazin C, Naoe T, Chen SJ, Wang ZY, Chen Z. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. Blood 1996, 88(3):1052-1061.
28. Qian M, Jin W, Zhu X, Jia X, Yang X, Du Y, Wang K, Zhang J. Structurally differentiated cis-elements that interact with PU.1 are functionally distinguishable in acute promyelocytic leukemia. J Hematol Oncol 2013, 6:25. 10.1186/1756-8722-6-25, 3618267, 23547873.
29. Spector DL. SnapShot: cellular bodies. Cell 2006, 127(5):1071.
30. Zhong S, Hu P, Ye TZ, Stan R, Ellis NA, Pandolfi PP. A role for PML and the nuclear body in genomic stability. Oncogene 1999, 18(56):7941-7947.